132 related articles for article (PubMed ID: 31462069)
21. Vitiligo-like depigmentation in patients with stage III-IV melanoma receiving immunotherapy and its association with survival: a systematic review and meta-analysis.
Teulings HE; Limpens J; Jansen SN; Zwinderman AH; Reitsma JB; Spuls PI; Luiten RM
J Clin Oncol; 2015 Mar; 33(7):773-81. PubMed ID: 25605840
[TBL] [Abstract][Full Text] [Related]
22. Melanoma outcomes for Medicare patients: association of stage and survival with detection by a dermatologist vs a nondermatologist.
Pennie ML; Soon SL; Risser JB; Veledar E; Culler SD; Chen SC
Arch Dermatol; 2007 Apr; 143(4):488-94. PubMed ID: 17438181
[TBL] [Abstract][Full Text] [Related]
23. Is sex an independent prognostic factor in cutaneous head and neck melanoma?
Arce PM; Camilon PR; Stokes WA; Nguyen SA; Lentsch EJ
Laryngoscope; 2014 Jun; 124(6):1363-7. PubMed ID: 24122966
[TBL] [Abstract][Full Text] [Related]
24. Action profiles of predictors of death and survival time in stage I malignant melanoma.
Helfenstein U; Schuler G; Morf S; Schuler D
Dermatology; 1996; 192(1):1-7. PubMed ID: 8832942
[TBL] [Abstract][Full Text] [Related]
25. Variation in incidence of breast, lung and cervical cancer and malignant melanoma of skin by socioeconomic group in England.
Shack L; Jordan C; Thomson CS; Mak V; Møller H;
BMC Cancer; 2008 Sep; 8():271. PubMed ID: 18822122
[TBL] [Abstract][Full Text] [Related]
26. Rurality index score and pediatric neuro-oncological outcome in Ontario.
Kameda-Smith MM; Pond GR; Seow H
J Neurosurg Pediatr; 2023 Apr; 31(4):275-281. PubMed ID: 36640100
[TBL] [Abstract][Full Text] [Related]
27. Impact of socioeconomic status and district of residence on cutaneous malignant melanoma prognosis: a survival study on incident cases between 1991 and 2011 in the province of Ferrara, northern Italy.
Borghi A; Corazza M; Virgili A; Lambertini AG; Caranci N; Pacelli B; Carcoforo P; Ferretti S
Melanoma Res; 2017 Dec; 27(6):619-624. PubMed ID: 28723726
[TBL] [Abstract][Full Text] [Related]
28. Primary Tumor Thickness is a Prognostic Factor in Stage IV Melanoma: A Retrospective Study of Primary Tumor Characteristics.
Luen S; Wong SW; Mar V; Kelly JW; McLean C; McArthur GA; Haydon A
Am J Clin Oncol; 2018 Jan; 41(1):90-94. PubMed ID: 26325493
[TBL] [Abstract][Full Text] [Related]
29. Socioeconomic status and the prevalence of melanoma in Ontario, Canada.
Haider A; Mamdani M; Shear NH
J Cutan Med Surg; 2007; 11(1):1-3. PubMed ID: 17274932
[TBL] [Abstract][Full Text] [Related]
30. Epidemiological features and prognostic factors of cutaneous head and neck melanoma: a population-based study.
Golger A; Young DS; Ghazarian D; Neligan PC
Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):442-7. PubMed ID: 17515502
[TBL] [Abstract][Full Text] [Related]
31. Effect of Teledermatology on Access to Dermatology Care Among Medicaid Enrollees.
Uscher-Pines L; Malsberger R; Burgette L; Mulcahy A; Mehrotra A
JAMA Dermatol; 2016 Aug; 152(8):905-12. PubMed ID: 27144986
[TBL] [Abstract][Full Text] [Related]
32. Association of increased dermatologist density with lower melanoma mortality.
Aneja S; Aneja S; Bordeaux JS
Arch Dermatol; 2012 Feb; 148(2):174-8. PubMed ID: 22351816
[TBL] [Abstract][Full Text] [Related]
33. Management and outcome of metastatic melanoma during pregnancy.
Pagès C; Robert C; Thomas L; Maubec E; Sassolas B; Granel-Brocard F; Chevreau C; De Raucourt S; Leccia MT; Fichet D; Khammari A; Boitier F; Stoebner PE; Dalac S; Celerier P; Aubin F; Viguier M
Br J Dermatol; 2010 Feb; 162(2):274-81. PubMed ID: 19804595
[TBL] [Abstract][Full Text] [Related]
34. Screening for Skin Cancer in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Wernli KJ; Henrikson NB; Morrison CC; Nguyen M; Pocobelli G; Blasi PR
JAMA; 2016 Jul; 316(4):436-47. PubMed ID: 27458949
[TBL] [Abstract][Full Text] [Related]
35. Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial.
Amaria RN; Prieto PA; Tetzlaff MT; Reuben A; Andrews MC; Ross MI; Glitza IC; Cormier J; Hwu WJ; Tawbi HA; Patel SP; Lee JE; Gershenwald JE; Spencer CN; Gopalakrishnan V; Bassett R; Simpson L; Mouton R; Hudgens CW; Zhao L; Zhu H; Cooper ZA; Wani K; Lazar A; Hwu P; Diab A; Wong MK; McQuade JL; Royal R; Lucci A; Burton EM; Reddy S; Sharma P; Allison J; Futreal PA; Woodman SE; Davies MA; Wargo JA
Lancet Oncol; 2018 Feb; 19(2):181-193. PubMed ID: 29361468
[TBL] [Abstract][Full Text] [Related]
36. Changing trends in melanoma treatment and the expanding role of the dermatologist.
Brown MD; Johnson TM; Swanson NA
Dermatol Clin; 1991 Oct; 9(4):657-67. PubMed ID: 1934641
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of Immunosuppressed Patients Who Develop Melanoma: A Population-Based Propensity-Matched Cohort Study.
Austin J; Wright FC; Cheng SY; Sutradhar R; Baxter NN; Look Hong NJ
Ann Surg Oncol; 2020 Aug; 27(8):2927-2948. PubMed ID: 32248374
[TBL] [Abstract][Full Text] [Related]
38. Improved Survival with Immunotherapy but Lack of Synergistic Effect with Radiation for Stage IV Melanoma of the Head and Neck.
Babcock B; Rodrigues M; Kearns D; Solomon N; Reeves ME; Senthil M; Garberoglio CA; Namm JP
Am Surg; 2019 Oct; 85(10):1118-1124. PubMed ID: 31657306
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology and survival outcomes of ocular and mucosal melanomas: a population-based analysis.
Bishop KD; Olszewski AJ
Int J Cancer; 2014 Jun; 134(12):2961-71. PubMed ID: 24272143
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
